Desmopressin0 vendors competing
No vendor pricing available for this peptide yet.
Research details
Desmopressin — research data
Regulatory statusFDA-approved (DDAVP)
NCAA D1Banned
Overview
About Desmopressin
Mechanism of action
Selective V2 receptor agonist; antidiuretic without vasopressor effect
Safety profile
Hyponatremia, headache, fluid retention · Decades of use; hyponatremia risk manageable with monitoring; very well-characterized
Related pages